Vivek S. Purohit

1.9k citations
52 papers · 1.3k indexed · 2 hit papers · h-index 18
Topics
Dermatology and Skin Diseases (12 papers)Hemophilia Treatment and Research (10 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)

In The Last Decade

Vivek S. Purohit

50 papers receiving 1.3k citations

Hit Papers

Topical tofacitinib for atopic dermatitis: a phase II a r...201620262019202220162023100200300

Peers

Vivek S. Purohit
Comparison fields: 5 of 87
  • Dermatology 628
  • Immunology and Allergy 376
  • Immunology 306
  • Molecular Biology 225
  • Rheumatology 214
Replace Karen Page with:
Karen Page United States
Scott Steward-Tharp United States
John C. Minnerly United States
Martina Sanlorenzo Italy
Igor Vujic Austria
Arthur P. Bertolino United States
Fumi Miyagawa Japan
Patricia Bacon United States
Peter Kaskel Germany
Martin Hülsmeyer Germany
Vivek S. Purohit relative to Karen Page United States Karen Page's profile →
Citations per field
00.5×8.5×
Karen Page · 1×
Citations per year

Countries citing papers authored by Vivek S. Purohit

Since Specialization
Citations

This map shows the geographic impact of Vivek S. Purohit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek S. Purohit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek S. Purohit more than expected).

Fields of papers citing papers by Vivek S. Purohit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek S. Purohit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek S. Purohit. The network helps show where Vivek S. Purohit may publish in the future.

Co-authorship network of co-authors of Vivek S. Purohit

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek S. Purohit. A scholar is included among the top collaborators of Vivek S. Purohit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek S. Purohit. Vivek S. Purohit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 7
4 1
5 11
6 11
7 4
8
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trialbreakdown →
134
9 3
10 95
11 15
12
Topical tofacitinib for atopic dermatitis: a phase II a randomized trialbreakdown →
320
13 18
14 12
15 12
16 38
17 16
18 19
19 23
20 6

About Vivek S. Purohit

Vivek S. Purohit is a scholar working on Dermatology, Immunology and Allergy and Hematology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (12 papers), Hemophilia Treatment and Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Dermatology (628 citations), Immunology and Allergy (376 citations) and Urology (123 citations). Vivek S. Purohit has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Robert Bissonnette, Sathyamangalam V. Balasubramanian, Melinda Gooderham, Carla Mamolo, Kim Papp, C. Russell Middaugh, Lotus Mallbris, William C. Ports, Yves Poulin and Maitreyi Raman. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026